GlassScriptPhysician profile
Kenneth John G Lim
NPI 1679705974
$1,571.55
in general payments reported to CMS, 2019-2025
18 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $42.76 · 2021: $16.91 · 2022: $69.48 · 2023: $400 · 2024: $543 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.45 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $296.78 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $270.82 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $181.70 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Exact Sciences Corporation | $180.22 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $116.76 | 2019-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Amgen INC. | $80.14 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $65.68 | 2023-2024 | Mounjaro, Zepbound |
| Abbott Laboratories | $65.05 | 2022-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $59.40 | 2019-2020 | |
| Dynavax Technologies Corporation | $43.87 | 2023 | Heplisav-B |
| Merck Sharp & Dohme LLC | $39.46 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Phadia US INC. | $38.85 | 2024 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.81 | 2019-2024 | Jardiance |
| Inspire Medical Systems, INC. | $24.48 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.92 | 2024 | |
| Dermira, INC. | $16.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth John Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.